Investment
Features
FeesSafety
Academy
More
Pluang+

Compare abrdn Income Credit Strategies Fund (ACP) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

abrdn Income Credit Strategies FundTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

abrdn Income Credit Strategies Fund vs DENTSPLY SIRONA Inc — how do they compare? abrdn Income Credit Strategies Fund trades at $5.11 (market cap $637.39M), while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.32B). The key difference: DENTSPLY SIRONA Inc is far larger — about 3.6× abrdn Income Credit Strategies Fund's market cap, and abrdn Income Credit Strategies Fund pays the higher dividend (18.31%). Which is the better fit depends on your goals.

ACPXRAY
Market Cap
$637.39M$2.32B
Sector
FinancialsHealth
52-Week High
$5.98$14.68
52-Week Low
$5.01$9.64
Dividend Yield
18.31%5.04%
Enterprise Value
$4.40B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

abrdn Income Credit Strategies Fund

ACP trades at $5.08, up 0.4% today, with a bearish technical signal from moving averages and a neutral stance from oscillators. The stock shows a low P/E of 7.7 and P/B of 0.9, indicating potential undervaluation, while net income margin remains high at 95.31%. Recent news highlights dividend declarations but also concerns over distribution sustainability from Seeking Alpha (2026-05-29).

The outlook is mixed: attractive valuation and dividends offer income appeal, but technical weakness and high distribution reliance pose risks. Investors should weigh the fund's high yield against credit spread tightness and leverage exposure noted in analyst reports.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $12.12, down 7.97% in 24 hours, with a bearish technical signal and support near $12. The company reported Q2 2026 EPS of $0.52, beating expectations, but revenue declined 4.1% year-over-year. Financials show negative net income margins and ROE, though gross margins remain solid at 49.52%. Recent news highlights institutional stake increases and strategic partnerships, such as the expanded Medline Sinclair relationship in Canada.

The outlook is cautious due to persistent revenue declines and profitability challenges, offset by cost-cutting efforts and digital dentistry growth. Risks include weak European demand and high debt levels, while analyst consensus is Hold with a $11.50 price target, indicating limited near-term upside amid turnaround execution uncertainties.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About abrdn Income Credit Strategies Fund

abrdn Income Credit Strategies Fund is a diversified, closed-end investment management company. Its primary goal is to generate high current income, with capital appreciation as a secondary objective. The fund mainly invests in debt and loan instruments from issuers across various industries and regions.

Read more on ACP

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY